Thermo Fisher Scientific | TMO - Операционный доход





Операционный доход Изменить Дата
Abbott USD 1.85B 399M 2026-03
Agilent USD 399M 46M 2026-03
Becton, Dickinson and Co. USD 627M 36M 2026-03
Bio Techne USD 75.49M 21.03M 2026-03
Bio-Rad Laboratories USD 53.9M 10M 2025-12
Boston Scientific USD 1.05B 190M 2026-03
Bruker USD 10.2M 66.1M 2026-03
Charles River Laboratories USD 119.9M 44.08M 2026-03
Danaher USD 1.34B 158M 2026-03
Dentsply International USD 32M 506M 2026-03
Edwards Lifesciences USD 514.7M 144.4M 2026-03
General Electric Aerospace USD 2.32B 549M 2026-03
Henry Schein USD 182M 4M 2026-03
Illumina USD 239M 17M 2026-03
Intuitive Surgical USD 859.7M 5.6M 2026-03
IQVIA Holdings USD 565M 2.11B 2026-03
Laboratory Of America USD 410.1M 28.1M 2026-03
Medtronic USD 2.09B 354M 2026-03
Mettler Toledo International USD 233.93M 118M 2026-03
Myriad Genetics USD -3M 20.3M 2025-12
Olympus JPY 26.87B 1.14B 2026-03
OraSure Technologies USD -13.59M 2.13M 2025-12
Quest Diagnostics USD 399M 13M 2026-03
Repligen USD 19.98M 13K 2026-03
Revvity USD 82.77M 63.06M 2026-03
Stryker USD 1.1B 867M 2026-03
Thermo Fisher Scientific USD 1.91B 389M 2026-03
Veracyte USD 19.08M 5.55M 2026-03
Waters USD 148M 122.52M 2026-03
Zimmer Biomet Holdings USD 395.1M 92.2M 2026-03